CoV-GLUE Lineage

CoV-GLUE Lineage: AY.95

Table of countries and their respective (filtered) sequence count for the lineage 'AY.95'.

Lineage	Country	Count	EarliestEpiWeek	LatestEpiWeek	View Mutations	59	60	61	62	63	64	65	66	67	68	69	70	71	72	73	74	75	76	77	78	79	80	81	82	83	84	85	86	87	88	89	90	91	92	93	94	95	96	97
AY.95	All	1314	59	97	Mutations	1	0	0	0	3	1	0	1	2	0	0	3	8	7	12	14	26	13	42	38	51	44	56	75	83	67	71	60	62	90	60	75	81	65	50	74	54	12	6
AY.95	MALDIVES	404	70	95		0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	4	0	1	3	0	4	0	9	6	22	0	26	17	22	54	2	42	48	36	27	46	33	0	0
AY.95	USA	153	71	97		0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	1	6	11	6	7	10	5	11	15	7	16	10	9	4	6	10	9	5	2
AY.95	BULGARIA	111	76	93		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	7	4	12	8	27	11	21	5	3	3	3	1	0	1	0	1	0	0	0	0
AY.95	NETHERLANDS	89	73	93		0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	2	2	4	20	15	23	8	1	3	3	2	0	1	0	1	0	0	0	0	1	0	0	0	0
AY.95	GERMANY	81	73	97		0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	5	3	1	0	0	0	1	0	5	3	1	10	8	6	5	7	7	9	4	0	0	1	3	1
AY.95	UK-ENGLAND	40	72	96		0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	2	0	0	3	3	0	0	1	1	2	7	2	4	3	2	2	0
AY.95	INDIA	38	59	92		1	0	0	0	0	1	0	1	2	0	0	1	0	2	2	0	0	1	2	0	1	2	2	4	3	1	1	0	3	3	0	0	0	4	0	0	0	0	0
AY.95	ITALY	35	72	94		0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	3	2	2	4	6	6	3	2	0	0	0	0	0	0	1	0	2	0	0	0
AY.95	TURKEY	32	63	97		0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	9	0	2	0	1	0	0	11	0	0	0	0	1	0	0	2	0	2	0	0	2
AY.95	CZECH_REPUBLIC	31	71	93		0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	3	1	1	7	5	5	2	1	0	1	3	0	0	0	1	0	0	0	0
AY.95	SOUTH_AFRICA	31	75	94		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	5	4	1	1	4	2	2	3	3	1	0	0	1	2	0	0	0
AY.95	SRI_LANKA	30	75	96		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	4	0	0	1	0	0	4	0	5	5	2	1	0	0	4	2	1	0
AY.95	AUSTRALIA	23	71	89		0	0	0	0	0	0	0	0	0	0	0	0	3	1	2	0	14	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0
AY.95	SPAIN	20	74	86		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	4	8	0	0	1	0	2	1	1	1	0	0	0	0	0	0	0	0	0	0	0
AY.95	DENMARK	18	81	97		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	10	3	1	1	0	1	0	0	0	0	0	0	0	0	1
AY.95	NORWAY	18	86	90		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	4	4	7	2	0	0	0	0	0	0	0
AY.95	BELGIUM	15	70	89		0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	1	1	1	0	1	0	1	3	2	1	1	0	0	0	0	0	0	0	0
AY.95	ISRAEL	14	71	95		0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	1	1	5	1	0	1	0	0
AY.95	MOZAMBIQUE	14	79	83		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	3	5	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	LITHUANIA	13	82	95		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	2	1	1	2	0	4	0	0
AY.95	LUXEMBOURG	12	87	93		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	2	5	2	0	0	0	0
AY.95	SWITZERLAND	11	72	96		0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	2	2	0	0	0	0	0	2	0	0	0	0	1	0	1	0
AY.95	FRANCE	8	79	93		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	2	0	0	0	1	0	0	1	0	1	0	1	0	0	0	0
AY.95	SWEDEN	7	79	93		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	0	0	3	0	0	0	0
AY.95	BANGLADESH	6	76	84		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	ETHIOPIA	6	84	85		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	JAPAN	5	73	84		0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	PORTUGAL	4	75	78		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	SLOVAKIA	4	83	85		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	2	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	SOUTH_KOREA	4	86	92		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	1	0	0	0	0	0
AY.95	POLAND	4	85	94		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	1	0	0	0
AY.95	RWANDA	4	63	87		0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0
AY.95	PERU	4	94	95		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0
AY.95	INDONESIA	3	72	89		0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0
AY.95	CANADA	2	81	81		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	AUSTRIA	2	73	73		0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	BAHRAIN	2	79	82		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	CHILE	2	90	90		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0
AY.95	SEYCHELLES	2	90	91		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0
AY.95	GREECE	2	89	89		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0
AY.95	UK-NORTHERN_IRELAND	1	-1	-1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	FINLAND	1	80	80		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	BRAZIL	1	85	85		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	KUWAIT	1	86	86		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0
AY.95	NIGERIA	1	85	85		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	MEXICO	1	89	89		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0
AY.95	AFGHANISTAN	1	71	71		0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AY.95	PHILIPPINES	1	86	86		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0
AY.95	JORDAN	1	94	94		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0
AY.95	CAMEROON	1	90	90		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.